Use of miR-327 inhibitors and/or FGF10 promoters in drugs for the prevention and/or treatment of lipodystrophy

A 1.mir-327, inhibitor technology, applied in the field of medicine, can solve problems such as health hazards and obesity

Active Publication Date: 2021-07-20
义慧科技(深圳)有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the commercially available drugs for the treatment of obesity, most of them are based on methods such as emetic induction and appetite suppression to reduce the intake of energy in the body so as to achieve the goal of weight loss, but this will cause certain harm to health and cannot radically change obesity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of miR-327 inhibitors and/or FGF10 promoters in drugs for the prevention and/or treatment of lipodystrophy
  • Use of miR-327 inhibitors and/or FGF10 promoters in drugs for the prevention and/or treatment of lipodystrophy
  • Use of miR-327 inhibitors and/or FGF10 promoters in drugs for the prevention and/or treatment of lipodystrophy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Embodiment 1 administers drugs to mice, and explores the influence of drugs on the weight and shape of adipose tissue

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides new applications of miR-327 inhibitors and / or FGF10 promoters, especially the applications in the preparation of drugs for preventing and / or treating diabetes. miR-327 inhibitors and FGF10 promoters can both promote the increase of FGF10 in the stromal cell components of adipose tissue, promote the differentiation of stromal cell component adipocyte precursors into brown adipocytes, increase energy consumption, and promote fat metabolism, thereby preventing And / or the effect of treating lipodystrophy. The present invention also provides a drug for preventing and / or treating lipodystrophy, including miR‑327 inhibitor and a pharmaceutically acceptable carrier thereof.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to the application of miR-327 inhibitors and / or FGF10 promoters in drugs for preventing and / or treating lipodystrophy. Background technique [0002] Fat metabolism is the process of digestion and absorption, synthesis and decomposition of fat in the body with the help of various related enzymes, and it is processed into the substances needed by the body to ensure the normal operation of physiological functions, which is of great significance to life activities. Diseases caused by abnormal fat metabolism are common diseases in modern society. Among them, obesity is a common fat metabolism disease, characterized by an increase in the volume and number of fat cells in the body leading to an abnormally high percentage of body fat in body weight and excessive fat deposition in some localities. According to statistics, 15%-20% of patients who die from diseases are accompanied by obesit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K45/06A61K38/18A61K31/7105A61P3/00
Inventor 杨云龙曹义海
Owner 义慧科技(深圳)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap